Abstract
Insulin resistance, cardiometabolic syndrome, and hypertension are common health problems with significant consequences for individuals and society. The pathogenesis of these disorders is complex and not fully understood. In this article we review the current knowledge about the effects of lifestyle modification and pharmacologic antihypertensive agents on insulin resistance and hypertension.
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Antihypertensive Agents / therapeutic use
-
Cardiovascular Agents / therapeutic use
-
Endothelium, Vascular / physiopathology
-
Humans
-
Hypertension / drug therapy*
-
Hypertension / physiopathology*
-
Inflammation / physiopathology
-
Insulin Resistance / physiology*
-
Life Style
-
Mineralocorticoid Receptor Antagonists
-
Obesity / physiopathology
-
Renin / antagonists & inhibitors
-
Renin-Angiotensin System / physiology
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin II Type 1 Receptor Blockers
-
Angiotensin-Converting Enzyme Inhibitors
-
Antihypertensive Agents
-
Cardiovascular Agents
-
Mineralocorticoid Receptor Antagonists
-
Renin